We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » NCI Role Looms Large in Potential Von Eschenbach Nomination as Permanent FDA Commissioner
NCI Role Looms Large in Potential Von Eschenbach Nomination as Permanent FDA Commissioner
March 13, 2006
Andrew von Eschenbach's dual role as acting FDA commissioner and head of the National Cancer Institute (NCI) is a key factor in arguments both for and against his likely nomination to become the permanent FDA commissioner, sources say.